Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2018 Jan 14;39(3):213-260.
doi: 10.1093/eurheartj/ehx419.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)

Marco Valgimigli, Héctor Bueno, Robert A Byrne, Jean-Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe Kolh, Laura Mauri, Gilles Montalescot, Franz-Josef Neumann, Mate Petricevic, Marco Roffi, Philippe Gabriel Steg, Stephan Windecker, Jose Luis Zamorano, Glenn N Levine; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies
Collaborators
Free article
Practice Guideline

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)

Marco Valgimigli et al. Eur Heart J. .
Free article
No abstract available

Keywords: Acute coronary syndromes; Aspirin; Bleeding; Clopidogrel; Coronary artery bypass grafting; Coronary artery disease; DAPT score; Drug-eluting stents; Dual antiplatelet therapy; Guidelines; Myocardial infarction; Non-cardiac surgery; Oral anticoagulant; PRECISE-DAPT score; Percutaneous coronary intervention; Prasugrel; Recommendation; Revascularization; Risk stratification; Stable angina; Stable coronary artery disease; Stent thrombosis; Stents; Ticagrelor; Triple therapy.

PubMed Disclaimer

Publication types

MeSH terms

Substances